WHO ICTRP trial
Fluconazole versus Micafungin in neonates with suspected or culture-proven…
NL-OMON41553 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON41553 |
|---|---|
| Public title | Fluconazole versus Micafungin in neonates with suspected or culture-proven Candidiasis: a randomized pharmacokinetic and safety study |
| Scientific title | Fluconazole versus Micafungin in neonates with suspected or culture-proven Candidiasis: a randomized pharmacokinetic and safety study - Fluconazole versus Micafungin in neonates |
| Primary sponsor | INSERM |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | The Netherlands |
| Conditions | Infection sepsis;10017528;Infection;sepsis |
| Interventions | • Treatment: Randomization (1:1): Fluconazole (25mg/kg loading dose; 12mg/kg or 20 mg/kg daily according to gestational and postnatal age) OR Micafungin (15mg/kg loading dose; 10 mg/kg daily) • Pharmacokinetics (fluconazole or micafungin… |
| Registration date | May 11, 2015 |
| Target size | 18 |
| Secondary IDs | 2012-001916-41;NL45035.078.14 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: